4//SEC Filing
Yea Christopher 4
Accession 0001415889-25-022968
CIK 0001348911other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 7:46 PM ET
Size
9.5 KB
Accession
0001415889-25-022968
Insider Transaction Report
Form 4
Yea Christopher
CHIEF DEVELOPMENT OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-08-21+3,750→ 133,243 total - Exercise/Conversion
Restricted Stock Unit
2025-08-21−3,750→ 52,500 total→ Common Stock (3,750 underlying) - Sale
Common Stock
2025-08-22$13.22/sh−2,362$31,232→ 130,881 total
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F3]1/16th of the total restricted stock units subject to the Award shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on May 21, 2025, subject to continued service through each vesting date.
Documents
Issuer
KalVista Pharmaceuticals, Inc.
CIK 0001348911
Entity typeother
Related Parties
1- filerCIK 0001691102
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 7:46 PM ET
- Size
- 9.5 KB